- Home
- HST vs SNN Comparison
HST vs SNN Comparison
Compare HST & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HST | SNN |
|---|---|---|
| Founded | 1927 | 1856 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Industrial Specialties |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.9B | 13.9B |
| IPO Year | N/A | 1999 |
Fundamental Metrics
Financial Performance| Metric | HST | SNN |
|---|---|---|
| Price | $18.25 | $33.90 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 14 | 4 |
| Target Price | $18.54 | ★ $32.83 |
| AVG Volume (30 Days) | ★ 7.1M | 598.6K |
| Earning Date | 02-18-2026 | 02-24-2026 |
| Dividend Yield | ★ 5.24% | 2.20% |
| EPS Growth | 3.27 | ★ 59.91 |
| EPS | ★ 1.06 | 0.56 |
| Revenue | ★ $5,950,000,000.00 | $5,944,000,000.00 |
| Revenue This Year | $6.54 | $7.71 |
| Revenue Next Year | $1.75 | $5.23 |
| P/E Ratio | ★ $17.12 | $59.73 |
| Revenue Growth | ★ 6.44 | 5.35 |
| 52 Week Low | $12.22 | $23.69 |
| 52 Week High | $18.72 | $38.79 |
Technical Indicators
Market Signals| Indicator | HST | SNN |
|---|---|---|
| Relative Strength Index (RSI) | 54.05 | 60.02 |
| Support Level | $17.63 | $32.42 |
| Resistance Level | $18.69 | $33.25 |
| Average True Range (ATR) | 0.34 | 0.40 |
| MACD | -0.07 | 0.15 |
| Stochastic Oscillator | 56.88 | 86.79 |
Price Performance
Historical ComparisonAbout HST Host Hotels & Resorts Inc.
Host Hotels & Resorts owns 80 predominantly urban and resort upper-upscale and luxury hotel properties representing nearly 43,000 rooms, mainly in the United States. Host recently sold off the company's interests in a joint venture owning a portfolio of hotels throughout Europe and also sold other joint ventures that owned properties in Asia and the United States. The majority of Host's portfolio operates under the Marriott and Starwood brands.
About SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.